Cannon Wealth Management Services’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$259K Buy
+1,028
New +$221K 0.14% 81
2026
Q1
Sell
-919
Closed -$210K 86
2025
Q4
$210K Sell
919
-7
-0.8% -$1.59K 0.15% 79
2025
Q3
$214K Buy
+926
New +$189K 0.16% 78

Other funds holding ABBV

Cannon Wealth Management Services's ABBV Position: Q2 2026 in Review

Cannon Wealth Management Services opened a new position in AbbVie (ABBV) in Q2 2026: 1,028 shares worth $259K. The stake represents 0.14% of the portfolio and ranks #81 among its holdings. This is a return to the name: Cannon Wealth Management Services previously reported a position in ABBV as recently as Q4 2025.

Cannon Wealth Management Services first reported a position in ABBV in Q3 2025 and has held it in 3 quarters since. 4,187 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Cannon Wealth Management Services held 1,028 shares of AbbVie worth $259K as of Q2 2026.
  • AbbVie was a new Cannon Wealth Management Services position in Q2 2026.
  • AbbVie made up 0.14% of Cannon Wealth Management Services's portfolio in Q2 2026, its #81 holding.
  • Cannon Wealth Management Services first reported a position in AbbVie in Q3 2025 and has held it in 3 quarters since.
  • 4,187 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Cannon Wealth Management Services's 13F filing for Q2 2026, filed 11 Aug 2026.